Declan Doogan, Director at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 178,132 shares at $35.41 ($6.3M) on 2018-06-05, disclosed to the SEC on 2018-06-06.
Open-market sale of $6.3M BHVN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.05 | 39,453 | $1.4M | 22.0% |
| 2 | $35.05 | 39,453 | $1.4M | 22.0% |
| 3 | $35.41 | 49,463 | $1.8M | 27.9% |
| 4 | $35.41 | 49,463 | $1.8M | 27.9% |
| 5 | $36.00 | 300 | $11K | 0.2% |
| Total | $35.25 avg | 178,132 |
| $6.3M |
| 100% |
| Filing → |
| BHVN | SELL | 2022-02-11 | $5.0M | — | Filing → |
| BHVN | SELL | 2021-12-01 | $5.5M | — | Filing → |
| BHVN | SELL | 2021-11-17 | $8.8M | — | Filing → |